Summary: Retatrutide's long-term side effects are not yet fully established, but current trial data indicate gastrointestinal effects, increased resting heart rate, and potential risks consistent with the GLP-1 receptor agonist drug class
A., Gipson, C
Zafereo ME , McIver B, Vargas-Salas S, Domnguez JM, Steward DL, Holsinger FC, Kandil E, Williams M, Cruz F, Loyola S, Solar A, Roa JC, Len A, Droppelman N, Lobos M, Arias T, Kong CS, Busaidy N, Grubbs EG, Graham P, Stewart J, Tang A, Wang J, Orloff L, Henrquez M, Lagos M, Osorio M, Schachter D, Franco C, Medina F, Wohllk N, Diaz RE, Veliz J, Horvath E, Tala H, Pineda P, Arroyo P, Vasquez F, Traipe E, Marn L, Miranda G, Bruce E, Bracamonte M, Mena N, Gonzlez HE
The Link Between Tirzepatide and Insomnia The good news is that there is currently no definitive evidence that Tirzepatide directly causes insomnia
Notably, berberine may stimulate the production of bioactive GLP-1, a hormone that increases insulin release and promotes a feeling of fullness, which helps prevent overeating and supports sustainable weight management
Mitochondrial diseases are characterized by both a diminished capacity to produce ATP as well as an elevated production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) [3]
)
